ImageneBio (IMA) Revenue (2020 - 2024)
Historic Revenue for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $3.5 million.
- ImageneBio's Revenue rose 19535.86% to $3.5 million in Q3 2024 from the same period last year, while for Dec 2024 it was $3.5 million, marking a year-over-year decrease of 6179.46%. This contributed to the annual value of $9.2 million for FY2023, which is 4134.97% down from last year.
- Per ImageneBio's latest filing, its Revenue stood at $3.5 million for Q3 2024, which was up 19535.86% from $659000.0 recorded in Q4 2023.
- ImageneBio's Revenue's 5-year high stood at $20.2 million during Q4 2021, with a 5-year trough of $65000.0 in Q4 2020.
- Moreover, its 5-year median value for Revenue was $3.4 million (2022), whereas its average is $4.0 million.
- Its Revenue has fluctuated over the past 5 years, first soared by 3100307.69% in 2021, then plummeted by 8923.64% in 2022.
- Quarter analysis of 5 years shows ImageneBio's Revenue stood at $65000.0 in 2020, then surged by 31003.08% to $20.2 million in 2021, then crashed by 73.04% to $5.4 million in 2022, then plummeted by 87.91% to $659000.0 in 2023, then skyrocketed by 431.11% to $3.5 million in 2024.
- Its Revenue stands at $3.5 million for Q3 2024, versus $659000.0 for Q4 2023 and $1.2 million for Q3 2023.